|
Baseline characteristics of patients diagnosed with MRSA (1439 subjects; mean ± SD age 70.3 ± 18.3 years) and a matched population sample free of MRSA (14,090 subjects; mean ± SD age 69.9 ± 18.2 years) from GPRD (2001–2004) |
||||
| Characteristic |
Patients with MRSA |
Matched MRSA-free patients |
||
|
|
||||
| n |
Percentage |
n |
Percentage |
|
|
|
||||
| Male |
604 |
42.0% |
5988 |
42.5% |
|
|
||||
| Female |
835 |
58.0% |
8102 |
57.5% |
|
|
||||
| Co-morbidity in the 2 years prior to cohort entry |
||||
|
|
||||
| Diabetes |
162 |
11.3% |
877 |
6.2% |
| Cardiovascular disease |
98 |
6.8% |
467 |
3.3% |
| Stroke |
74 |
5.1% |
140 |
1.0% |
| Peripheral vascular disease |
34 |
2.4% |
72 |
0.5% |
| COPD |
76 |
5.3% |
364 |
2.6% |
| Renal failure |
45 |
3.1% |
138 |
1.0% |
| Cancer |
27 |
1.9% |
127 |
0.9% |
| Autoimmune disease |
12 |
0.8% |
66 |
0.5% |
| Drug exposure in the 1 year prior to cohort entry |
||||
| Oral prednisone use |
155 |
10.8% |
858 |
6.1% |
| Antibiotics |
1019 |
70.8% |
5369 |
38.1% |
Delaney et al. BMC Medicine 2008 6:2 doi:10.1186/1741-7015-6-2 |
||||